Adcetris FDA approval expanded to include later-stage Hodgkin's

(HealthDay)—U.S. Food and Drug Administration approval of Adcetris (brentuximab vedotin) has been expanded to include adults with untreated stage III or IV classical Hodgkin's lymphoma, the agency

Updated on: March 30,2024

Adcetris FDA approval expanded to include later-stage Hodgkin's

(HealthDay)—U.S. Food and Drug Administration approval of Adcetris (brentuximab vedotin) has been expanded to include adults with untreated stage III or IV classical Hodgkin's lymphoma, the agency

Updated on:March 30,2024

Actinidia arguta (sarunashi) juice found to inhibit lung cancer in mice

byOkayama UniversityA representative tumor (adenoma/adenocarcinoma) corresponding to the nodule counted macroscopically and the alveolar area around the tumor in the A/J mouse at 30 weeks of age

Updated on: January 02,2024

Actinidia arguta (sarunashi) juice found to inhibit lung cancer in mice

byOkayama UniversityA representative tumor (adenoma/adenocarcinoma) corresponding to the nodule counted macroscopically and the alveolar area around the tumor in the A/J mouse at 30 weeks of age

Updated on:January 02,2024

Researchers discover 40 genes involved in early development of myeloma

by Sarah Wells, The Institute of Cancer ResearchMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0Researchers have revealed 40 ge

Updated on: June 24,2024

Researchers discover 40 genes involved in early development of myeloma

by Sarah Wells, The Institute of Cancer ResearchMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0Researchers have revealed 40 ge

Updated on:June 24,2024

Stress-tolerant cells shown to drive tumor initiation in pancreatic cancer

by University of California - San DiegoTumor-initiating cells (blue) produce an extracellular matrix containing fibronectin (pink) which gives them increased stress tolerance, drug resistance and

Updated on: February 23,2024

Stress-tolerant cells shown to drive tumor initiation in pancreatic cancer

by University of California - San DiegoTumor-initiating cells (blue) produce an extracellular matrix containing fibronectin (pink) which gives them increased stress tolerance, drug resistance and

Updated on:February 23,2024

Stricter alcohol policies related to lower risk of cancer

by Boston Medical CenterCredit: CC0 Public DomainIn a new study, researchers at Boston Medical Center and Boston University have uncovered a new association between more restrictive alcohol polic

Updated on: March 01,2024

Stricter alcohol policies related to lower risk of cancer

by Boston Medical CenterCredit: CC0 Public DomainIn a new study, researchers at Boston Medical Center and Boston University have uncovered a new association between more restrictive alcohol polic

Updated on:March 01,2024

Medical physicist consults with patients can help reduce anxiety and increase satisfaction with radiation care

by American Society for Radiation OncologyCredit: Pixabay/CC0 Public DomainMeeting with a medical physicist who can explain how radiation therapy is planned and delivered reduces patient anxiety

Updated on: February 01,2024

Medical physicist consults with patients can help reduce anxiety and increase satisfaction with radiation care

by American Society for Radiation OncologyCredit: Pixabay/CC0 Public DomainMeeting with a medical physicist who can explain how radiation therapy is planned and delivered reduces patient anxiety

Updated on:February 01,2024

Some cancer immunotherapy treatments may damage fertility

by Monash UniversityCredit: Pixabay/CC0 Public DomainResearchers have discovered that some immunotherapy treatments used to treat cancer can cause fertility damage.It means these treatments could

Updated on: January 30,2024

Some cancer immunotherapy treatments may damage fertility

by Monash UniversityCredit: Pixabay/CC0 Public DomainResearchers have discovered that some immunotherapy treatments used to treat cancer can cause fertility damage.It means these treatments could

Updated on:January 30,2024

Experimental monoclonal antibodies can coax aggressive prostate and breast cancers into submission, finds research

by Delthia Ricks , Medical XpressTherapeutic inhibition of VEGF binding to NRP2 activates anti-tumor immunity in a syngeneic model of prostate cancer that is resistant to aPD-L1 therapy. (A) Shown is

Updated on: January 23,2024

Experimental monoclonal antibodies can coax aggressive prostate and breast cancers into submission, finds research

by Delthia Ricks , Medical XpressTherapeutic inhibition of VEGF binding to NRP2 activates anti-tumor immunity in a syngeneic model of prostate cancer that is resistant to aPD-L1 therapy. (A) Shown is

Updated on:January 23,2024

Over half of English patients with NSCLC in areas with low socio-economic levels do not receive anti-cancer therapies

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainNovel anti-cancer therapies were not accessible to more than half of the patients in England who were diagnose

Updated on: February 01,2024

Over half of English patients with NSCLC in areas with low socio-economic levels do not receive anti-cancer therapies

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainNovel anti-cancer therapies were not accessible to more than half of the patients in England who were diagnose

Updated on:February 01,2024

Study validates clinical utility of pan-tumor predictive biomarker for checkpoint inhibitor immunotherapy benefit

by Strata OncologyDevelopment of an integrative immunotherapy response score (IRS) model to stratify PD-(L)1 therapy benefit in patients with advanced solid tumors.aReal-world treatment an

Updated on: February 03,2024

Study validates clinical utility of pan-tumor predictive biomarker for checkpoint inhibitor immunotherapy benefit

by Strata OncologyDevelopment of an integrative immunotherapy response score (IRS) model to stratify PD-(L)1 therapy benefit in patients with advanced solid tumors.aReal-world treatment an

Updated on:February 03,2024

Researchers uncover aberrant natural killer cell subtype

by University of Science and Technology of ChinaGraphical Abstract. Credit:Cell(2023). DOI: 10.1016/j.cell.2023.07.034A team led by Prof. Tian Zhigang and Prof. Peng Hui from the Universit

Updated on: June 15,2024

Researchers uncover aberrant natural killer cell subtype

by University of Science and Technology of ChinaGraphical Abstract. Credit:Cell(2023). DOI: 10.1016/j.cell.2023.07.034A team led by Prof. Tian Zhigang and Prof. Peng Hui from the Universit

Updated on:June 15,2024

Study finds worsening metabolic syndrome increases the risk of developing cancer

by WileyCredit: Pavel Danilyuk from PexelsNew research indicates that individuals with persistent and worsening metabolic syndrome—which encompasses conditions such as high blood pressure, elevat

Updated on: March 20,2024

Study finds worsening metabolic syndrome increases the risk of developing cancer

by WileyCredit: Pavel Danilyuk from PexelsNew research indicates that individuals with persistent and worsening metabolic syndrome—which encompasses conditions such as high blood pressure, elevat

Updated on:March 20,2024